DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
Enhertu is a HER2-directed antibody drug conjugate (ADC) being jointly developed by AstraZeneca and Daiichi Sankyo.
The target demographic will be those between the ages of 30 and 65 years
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
Evusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US to prevent Covid-19
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
It is used for the treatment of advanced colorectal and gastric cancer
Subscribe To Our Newsletter & Stay Updated
